A 24-MONTH PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT - INTERIM ANALYSIS OF BASELINE CHARACTERISTICS

被引：0
|
作者：
Morel, Jacques [1 ,2 ,3 ]
Dagna, Lorenzo [4 ,5 ]
Ibanez, Beatriz Joven [6 ]
Holzkaemper, Thorsten [7 ]
El Baou, Celine [7 ]
Unger, Leonore [8 ]
Semeraro, Angelo [9 ]
Gullick, Nicola [10 ,11 ]
Treuer, Tamas [7 ]
机构：
[1] Univ Montpellier, Montpellier Sch Med, Rheumatol, Montpellier, France
[2] CHU Montpellier, Rheumatol, Montpellier, France
[3] Univ Montpellier, Montpellier, France
[4] IRCCS San Raffaele Hosp, Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
[5] Univ Vita Salute San Raffaele, Rheumatol, Milan, Italy
[6] Hosp Univ 12 Octubre, Rheumatol, Madrid, Spain
[7] Eli Lilly & Co, Rheumatol, Indianapolis, IN USA
[8] Klinikum Dresden, Rheumatol, Med Klin, Dresden, Germany
[9] Presidio Osped Valle Itria, Rheumatol, OU Reumatol, Piazza San Francesco Da Paola 1, Martina Franca, Italy
[10] Univ Warwick, Warwick Med Sch, Rheumatol, Coventry, W Midlands, England
[11] Univ Hosp Coventry & Warwickshire NHS Trust, Rheumatol, Coventry, W Midlands, England
来源：
RHEUMATOLOGY | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P184
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A 24-MONTH PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT (PRO-SPIRIT) - INTERIM ANALYSIS OF BASELINE CHARACTERISTICS
    Morel, J.
    Dagna, L.
    Joven-Ibanez, B.
    Holzkaemper, T.
    El Baou, C.
    Unger, L.
    Semeraro, A.
    Gullick, N.
    Treuer, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1578 - 1578
  • [2] STUDY DESIGN AND FULL BASELINE SAMPLE CHARACTERISTICS OF PATIENTS FROM THE 24-MONTH MULTINATIONAL PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT (PRO-SPIRIT)
    Morel, J.
    Lubrano, E.
    Tillett, W.
    Alten, R.
    Kristensen, L. E.
    Chandran, V.
    Treuer, T.
    Burke, J.
    Martinez-Ferrer, A.
    Holzkaemper, T.
    Gullick, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1786 - 1787
  • [3] Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT
    Gullick, Nicola
    Sheesh, Mohamed
    Laedermann, Cedric
    Ngantcha, Marcus
    Gittens, Beatrice
    Ng, Khai Jing
    Tillett, William
    Morel, Jacques
    Lubrano, Ennio
    Alten, Rieke
    Kristensen, Lars Erik
    Chandran, Vinod
    Martinez-Ferrer, Angels
    Kirkham, Bruce
    RHEUMATOLOGY, 2024, 63
  • [4] BASELINE CHARACTERISTICS OF PATIENTS INITIATING IXEKIZUMAB, SECUKINUMAB OR A TUMOUR NECROSIS FACTOR INHIBITOR BY COUNTRY IN THE 24-MONTH PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT - PRO-SPIRIT
    Gullick, Nicola
    Sheesh, Mohamed
    Laedermann, Cedric
    Ngantcha, Marcus
    Gittens, Beatrice
    Ng, Khai Jing
    Tillett, William
    Morel, Jacques
    Lubrano, Ennio
    Alten, Rieke
    Kristensen, Lars Erik
    Chandran, Vinod
    Martinez-Ferrer, Angels
    Kirkham, Bruce
    RHEUMATOLOGY, 2024, 63 : I153 - I154
  • [5] 12-MONTH PERSISTENCE WITH DENOSUMAB (DMAB) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO): INTERIM RESULTS OF A 24-MONTH PROSPECTIVE OBSERVATIONAL STUDY IN GERMANY, AUSTRIA, GREECE AND BELGIUM
    Hadji, P.
    Papaioannou, N. A.
    Gielen, E.
    Tepie, M. F.
    Zhang, E.
    Kalouche-Khalil, L.
    Fahrleitner-Pammer, A.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S181 - S182
  • [6] Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study
    Drosos, AA
    Voulgari, PV
    Papadopoulos, IA
    Politi, EN
    Georgiou, PE
    Zikou, AK
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (06) : 695 - 702
  • [7] Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
    Ramonda, Roberta
    Lorenzin, Mariagrazia
    Carriero, Antonio
    Chimenti, Maria Sole
    Scarpa, Raffaele
    Marchesoni, Antonio
    di Scorpaniello, Ennio Lubrano
    Salvarani, Carlo
    Cauli, Alberto
    Semeraro, Angelo
    Santo, Leonardo
    Ortolan, Augusta
    Doria, Andrea
    Fracassi, Elena
    Virelli, Giulia
    Masia, Marco
    Fanizzi, Rosalinda
    Visalli, Elisa
    Amato, Giorgio
    Carletto, Antonio
    Foti, Rosario
    RMD OPEN, 2021, 7 (01):
  • [8] Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
    Maria Sole Chimenti
    Augusta Ortolan
    Mariagrazia Lorenzin
    Paola Triggianese
    Marina Talamonti
    Luisa Costa
    Francesco Caso
    Marta Favero
    Miriam Teoli
    Marco Galluzzo
    Raffaele Scarpa
    Leonardo Punzi
    Roberto Perricone
    Roberta Ramonda
    Clinical Rheumatology, 2018, 37 : 397 - 405
  • [9] Effectiveness and safety of ustekinumab in na⟨ve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
    Chimenti, Maria Sole
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Triggianese, Paola
    Talamonti, Marina
    Costa, Luisa
    Caso, Francesco
    Favero, Marta
    Teoli, Miriam
    Galluzzo, Marco
    Scarpa, Raffaele
    Punzi, Leonardo
    Perricone, Roberto
    Ramonda, Roberta
    CLINICAL RHEUMATOLOGY, 2018, 37 (02) : 397 - 405
  • [10] Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Leo, Giovanni
    Pampaloni, Francesca
    Messina, Francesco
    Doria, Andrea
    Piaserico, Stefano
    Ramonda, Roberta
    DERMATOLOGY, 2022, 238 (05) : 897 - 903
12345